Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-23-028462

Chief Financial Officer gave up 834 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. Chief Financial Officer 2023-05-08 Shares withheld for taxes −834 $4.14 $3,453 153,625 D
Loading xslF345X04/doc4.xml…